Please login to the form below

Not currently logged in
Email:
Password:

Agios appoints Celgene’s Jackie Fouse

She joins the pharma group’s board of directors

Jackie FouseCancer and rare genetic disease focused group Agios Pharmaceuticals has appointed Jackie Fouse to its board of directors as the company prepares to launch its first precision medicine.

She said: “The execution across Agios’ research and clinical development programmes is remarkable, and I'm pleased to be joining the board during this exciting time.

“I look forward to working with the Agios team.”

Fouse’s career saw her join Celgene in 2010 as its chief financial officer and she most recently served as its president and chief operating officer until earlier this year.

Prior to her tenure at Celgene, Fouse worked for Alcon Laboratories, an ophthalmic pharmaceutical and medical device company.

David Schenkein, chief executive officer at Agios, said: “Through her tenure at Celgene we had the privilege of working with Jackie and seeing first hand the value she brings to a growing biotechnology company, so we are thrilled to welcome her to the Agios board of directors.”

14th December 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics